FDA Inspection 1090627 - Aurobindo Pharma Ltd - May 24, 2019

FDA Inspection 1090627 for Aurobindo Pharma Ltd on May 24, 2019. Classification: Voluntary Action Indicated (VAI).

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1090627 for Aurobindo Pharma Ltd on May 24, 2019. Classification: Voluntary Action Indicated (VAI).

Violation Codes

21 CFR 211.137(b)

21 CFR 211.170(a)

21 CFR 211.192

21 CFR 211.194(a)

21 CFR 211.198(b)(2)

21 CFR 211.22(d)

21 CFR 211.42(a)

21 CFR 211.67(b)

21 CFR 211.68(b)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Aurobindo Pharma Ltd

Inspection Date

May 24, 2019

Product Type

Drugs

Office

Center for Drug Evaluation and Research

ID: e3cd1f8d-155d-4a10-b7f7-2443f3cc028c

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox